Alterity Therapeutics (PRNAD) Change in Account Payables (2009 - 2020)

Alterity Therapeutics (PRNAD) has reported Change in Account Payables for 10 consecutive years, with -$425086.2 the latest figure, recorded in Q2 2020.

• In Q2 2020, Change in Account Payables fell 191.54% year-over-year to -$425086.2; the TTM figure through Jun 2020 stood at -$309780.3 (up 90.28% YoY), while the FY2025 annual figure was -$1.3 million, down 280.25% from the prior year.
• Change in Account Payables came in at -$425086.2 for Q2 2020 at Alterity Therapeutics, down from $64066.7 in the prior quarter.
• The five-year high for Change in Account Payables was $464361.3 in Q2 2019, with the low at -$3.2 million in Q4 2017.
• Average Change in Account Payables over 5 years is -$529981.3, with a median of -$301256.3 recorded in 2016.
• Across the five-year window, Change in Account Payables sank 1065.61% in 2017 and surged 5175.08% in 2019, its largest moves.
• Year by year, Change in Account Payables stood at -$278480.6 in 2016, then tumbled by 1065.61% to -$3.2 million in 2017, then surged by 87.27% to -$413122.1 in 2018, then soared by 115.51% to $64066.7 in 2019, then sank by 763.51% to -$425086.2 in 2020.
• According to Business Quant data, Change in Account Payables over the past three periods registered -$425086.2, $64066.7, and $464361.3 for Q2 2020, Q4 2019, and Q2 2019 respectively.